Cortes J, Jonas BA, Schiller G, Mims A, et al. Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (mIDH1) acute myeloid leukemia (AML). Leuk Lymphoma 2024 Mar 27:1-8. doi: 10.1080/10428194.2024.2333451.
PMID: 38538632